BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24519100)

  • 1. Accuracy of ovarian and colon cancer risk assessments by U.S. physicians.
    Baldwin LM; Trivers KF; Andrilla CH; Matthews B; Miller JW; Lishner DM; Goff BA
    J Gen Intern Med; 2014 May; 29(5):741-9. PubMed ID: 24519100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vignette-based study of ovarian cancer screening: do U.S. physicians report adhering to evidence-based recommendations?
    Baldwin LM; Trivers KF; Matthews B; Andrilla CH; Miller JW; Berry DL; Lishner DM; Goff BA
    Ann Intern Med; 2012 Feb; 156(3):182-94. PubMed ID: 22312138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician Nonprofessional Cancer Experience and Ovarian Cancer Screening Practices: Results from a National Survey of Primary Care Physicians.
    Ragland M; Trivers KF; Andrilla CHA; Matthews B; Miller J; Lishner D; Goff B; Baldwin LM
    J Womens Health (Larchmt); 2018 Nov; 27(11):1335-1341. PubMed ID: 30095327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
    Trivers KF; Baldwin LM; Miller JW; Matthews B; Andrilla CH; Lishner DM; Goff BA
    Cancer; 2011 Dec; 117(23):5334-43. PubMed ID: 21792861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline-inconsistent breast cancer screening for women over 50: a vignette-based survey.
    Kadivar H; Goff BA; Phillips WR; Andrilla CH; Berg AO; Baldwin LM
    J Gen Intern Med; 2014 Jan; 29(1):82-9. PubMed ID: 23943421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonrecommended breast and colorectal cancer screening for young women: a vignette-based survey.
    Kadivar H; Goff BA; Phillips WR; Andrilla CH; Berg AO; Baldwin LM
    Am J Prev Med; 2012 Sep; 43(3):231-9. PubMed ID: 22898115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer.
    Meier CR; Schmitz S; Jick H
    Pharmacotherapy; 2002 Mar; 22(3):303-9. PubMed ID: 11898889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history.
    Nelson CL; Sellers TA; Rich SS; Potter JD; McGovern PG; Kushi LH
    Genet Epidemiol; 1993; 10(4):235-44. PubMed ID: 8224804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do physicians tailor their recommendations for breast cancer risk reduction based on patient's risk?
    Haas JS; Kaplan CP; Gregorich SE; PĂ©rez-Stable EJ; Des Jarlais G
    J Gen Intern Med; 2004 Apr; 19(4):302-9. PubMed ID: 15061738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
    MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
    Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family physicians' perspectives on ovarian cancer.
    Gray RE; Chart P; Carroll JC; Fitch MI; Cloutier-Fisher D
    Cancer Prev Control; 1999 Feb; 3(1):61-7. PubMed ID: 10474754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and intervention for intimate partner abuse: practices and attitudes of primary care physicians.
    Rodriguez MA; Bauer HM; McLoughlin E; Grumbach K
    JAMA; 1999 Aug; 282(5):468-74. PubMed ID: 10442663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality.
    Stewart SL; Townsend JS; Puckett MC; Rim SH
    J Womens Health (Larchmt); 2016 Mar; 25(3):235-41. PubMed ID: 26978124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician knowledge and awareness of CA-125 as a screen for ovarian cancer in the asymptomatic, average-risk population.
    Stewart SL; Rim SH; Gelb CA
    Health Educ Behav; 2012 Feb; 39(1):57-66. PubMed ID: 21680807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial.
    Rubinstein WS; Acheson LS; O'Neill SM; Ruffin MT; Wang C; Beaumont JL; Rothrock N;
    Genet Med; 2011 Nov; 13(11):956-65. PubMed ID: 22075527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity and risk of colon cancer: the Physicians' Health Study (United States).
    Lee IM; Manson JE; Ajani U; Paffenbarger RS; Hennekens CH; Buring JE
    Cancer Causes Control; 1997 Jul; 8(4):568-74. PubMed ID: 9242472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of gynecologic oncologists in the treatment of patients with a suspicious ovarian mass.
    Goff BA; Miller JW; Matthews B; Trivers KF; Andrilla CH; Lishner DM; Baldwin LM
    Obstet Gynecol; 2011 Oct; 118(4):854-62. PubMed ID: 21934449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's awareness of ovarian cancer risks and symptoms.
    Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
    Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U.S. practices for colon cancer screening.
    Hendon SE; DiPalma JA
    Keio J Med; 2005 Dec; 54(4):179-83. PubMed ID: 16452827
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.